PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Synthetic derivatives of THC may weaken HIV-1 infection to enhance antiviral therapies

New research published in the Journal of Leukocyte Biology suggests compounds that stimulate the cannabinoid type 2 receptor in white blood cells, specifically macrophages, can weaken HIV-1 infection

2013-04-30
(Press-News.org) A new use for compounds related in composition to the active ingredient in marijuana may be on the horizon: a new research report published in the Journal of Leukocyte Biology shows that compounds that stimulate the cannabinoid type 2 (CB2) receptor in white blood cells, specifically macrophages, appear to weaken HIV-1 infection. The CB2 receptor is the molecular link through which the pharmaceutical properties of cannabis are manifested. Diminishing HIV-1 infection in this manner might make current anti-viral therapies more effective and provide some protection against certain HIV-1 complications.

"The synthetic compounds we used in our study may show promise in helping the body fight HIV-1 infection,'" said Yuri Persidsky, M.D., Ph.D., a researcher involved in the work from the Department of Pathology and Laboratory Medicine at Temple University School of Medicine in Philadelphia, PA. "As compounds like these are improved further and made widely available, we will continue to explore their potential to fight other viral diseases that are notoriously difficult to treat."

To make this discovery, scientists used a cell culture model to infect human macrophages with HIV-1 and added synthetic compounds similar to the active ingredient in marijuana to activate the CB2 receptor. At different times during the infection, samples from the culture were taken to see if the replication of the HIV virus was decreased. The researchers observed diminished HIV growth and a possible protective effect from some HIV-1 complications.

"HIV/AIDS has posed one of the most significant health challenges in modern medicine," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "Recent high profile vaccine failures mean that all options need to be on the table to prevent or treat this devastating infection. Research on the role of cannabinoid type 2 receptors and viral infection may one day allow targeting these receptors to be part of combination therapies that use exploit multiple weaknesses of the virus simultaneously."

### The Journal of Leukocyte Biology publishes peer-reviewed manuscripts on original investigations focusing on the cellular and molecular biology of leukocytes and on the origins, the developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes and other cells involved in host defense and inflammation. The Journal of Leukocyte Biology is published by the Society for Leukocyte Biology.

Details: Servio H. Ramirez, Nancy L. Reichenbach, Shongshan Fan, Slava Rom, Steven F. Merkel, Xu Wang, Wen-zhe Ho, and Yuri Persidsky. Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists. J. Leukoc. Biol. May 2013 93:801-810; doi:10.1189/jlb.1012523 ; http://www.jleukbio.org/content/93/5/801.abstract END


ELSE PRESS RELEASES FROM THIS DATE:

Intervention can prevent PPD in adolescents

2013-04-30
By targeting the factors that may play a significant role in the development of postpartum depression (PPD) in adolescent mothers, researchers at Women & Infants Hospital of Rhode Island believe they have found a way to prevent it. The team – led by Maureen G. Phipps, MD, MPH, interim chief of obstetrics and gynecology and director of the Division of Research at Women & Infants, and Caron Zlotnick, PhD, of the hospital's Center for Women's Behavioral Health – recently published "Randomized controlled trial to prevent postpartum depression in adolescent mothers" in the ...

Shifting the burden of recycling

2013-04-30
Over the past two decades governments around the world have been experimenting with a new strategy for managing waste. By making producers responsible for their products when they become wastes, policy makers seek to significantly increase the recycling—and recyclability—of computers, packaging, automobiles, and household hazardous wastes such as batteries, used oil motor, and leftover paint—and save money in the process. This strategy, known as extended producer responsibility (EPR), is the subject of a new special feature in Yale University's Journal of Industrial ...

Study finds possible alternative to bariatric weight loss surgery

2013-04-30
CINCINNATI – An experimental procedure successfully tested in obese laboratory rats may provide a less-invasive alternative to bariatric weight-loss surgery, researchers report online in Endocrinology. Scientists at Cincinnati Children's Hospital Medical Center used a catheter to re-direct the flow of bile from the bile duct into the small intestine, producing the same metabolic and weight-loss benefits as bariatric surgeries such as gastric by-pass. They named the procedure bile diversion, or BD. "This may lead to novel ways to treat obesity related conditions," said ...

Cruise tourists spend less

2013-04-30
More and more cruise ships visit the fjords of Western Norway. But cruise tourists only spend a fraction of what other tourists spend. Over the past few years, the overall number of tourists to Western Norway has declined slightly. But one group of tourists is steadily rising: the cruise ship passenger. However, the cruise ship industry matters little to the tourism industry onshore. The average camping tourist leaves behind twice as much as the average cruise ship tourist. And this even when one excludes costs and taxes for camping, says Professor Svein Larsen of the ...

Carnegie Mellon develops zooming technique for entering text into smartwatches

2013-04-30
PITTSBURGH—Technology blogs have been abuzz that smartwatches may soon be on their way from companies such as Apple, Google, Samsung and Microsoft. But as capable as these ultra-small computers may be, how will users enter an address, a name, or a search term into them? One solution is an iterative zooming technique developed and tested by researchers at Carnegie Mellon University. Called ZoomBoard, this text entry technique is based on the familiar QWERTY keyboard layout. Though the full keyboard is impossibly small on a watch-size display, simply tapping the screen ...

Environmental labels may discourage conservatives from buying energy-efficient products

2013-04-30
DURHAM, N.C. -- When it comes to deciding which light bulb to buy, a label touting the product's environmental benefit may actually discourage politically conservative shoppers. Dena Gromet and Howard Kunreuther at The University of Pennsylvania's Wharton School and Rick Larrick at Duke University's Fuqua School of Business conducted two studies to determine how political ideology affected a person's choice to buy energy-efficient products in the United States. The authors suggest that financial incentives or emphasizing energy independence may be better ways to get ...

UMass Amherst biologists propose a new research roadmap for connecting genes to ecology

2013-04-30
AMHERST, Mass. – A team of researchers at the University of Massachusetts Amherst is proposing a new investigative roadmap for the field of evolutionary developmental biology, or "evo devo," to better understand how innovation at the genetic level can lead to ecological adaptations over time. Evo devo seeks to understand the specific genetic mechanisms underlying evolutionary change. Seven UMass Amherst authors, all biologists but with diverse research programs including evolutionary genetics, developmental biology, biomechanics and behavioral ecology, describe the new ...

Experts discuss ways to embed patient voices and values in clinical research

2013-04-30
Rochester, MN, April 30, 2013 – There is worldwide concern in the biomedical research community that enrollment in clinical trials is lagging, putting clinical research and consequent benefits to society in jeopardy. Experts explore ways to embed patient voices and values in clinical research in the current issue of Mayo Clinic Proceedings. Clinical trials of new drugs, devices, or procedures require the active participation of human volunteers. Mark A. Yarborough, PhD, of the Bioethics Program, University of California Davis, calls for greater transparency about the ...

Identification of stem cells raises possibility of new therapies

2013-04-30
WINSTON-SALEM, N.C., – April 30, 2013 – Many diseases – obesity, Type 2 diabetes, muscular dystrophy – are associated with fat accumulation in muscle. In essence, fat replacement causes the muscles to weaken and degenerate. Scientists at Wake Forest Baptist Medical Center have discovered the biological mechanism involved in this process, which could point the way to potential therapies. The findings are published in the April 27 online edition of Stem Cells and Development. The Wake Forest Baptist researchers proved that pericytes, stem cells associated with blood vessels, ...

Agencies should use common approach to evaluate risks pesticides pose to endangered species

2013-04-30
WASHINGTON -- When determining the potential effects pesticides could pose to endangered or threatened species, the U.S. Environmental Protection Agency, National Marine Fisheries Service (NMFS), and Fish and Wildlife Service (FWS) should use a common scientific approach, says a new report from the National Research Council. Specifically, the agencies should use a risk assessment approach that addresses problem formulation, exposure analysis, effects analysis, and risk characterization. Under the Federal Insecticide, Fungicide, and Rodenticide Act, before a pesticide ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Synthetic derivatives of THC may weaken HIV-1 infection to enhance antiviral therapies
New research published in the Journal of Leukocyte Biology suggests compounds that stimulate the cannabinoid type 2 receptor in white blood cells, specifically macrophages, can weaken HIV-1 infection